Organization Profile

You just read:

FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency

News provided by

Aeterna Zentaris Inc.

Nov 06, 2014, 07:00 ET